MyFinsight
Home
Blog
About
Contact
Download
Download image
Change in fair value of
contingent earnout...
-$4,893K
(-157.64%↓ Y/Y)
Change in fair value of
derivatives
$4,009K
(282.90%↑ Y/Y)
Interest income
$590K
(-35.24%↓ Y/Y)
Net loss
-$17,510K
(55.33%↑ Y/Y)
Total other income
(expense), net
$6,880K
(176.71%↑ Y/Y)
Product
$703K
Product And Service
Other
$50K
Interest expense
$2,612K
(7.14%↑ Y/Y)
Loss from operations
-$24,390K
(19.33%↑ Y/Y)
Total revenue
$753K
Total operating
expenses
$25,143K
(-16.84%↓ Y/Y)
Research and development
$17,273K
(-24.66%↓ Y/Y)
Selling, general and
administrative
$7,610K
Cost of goods sold
$260K
Back
Back
Income Statement
source: myfinsight.com
Humacyte, Inc. (HUMA)
Humacyte, Inc. (HUMA)